Figures computed from official regulatory filings — .
Analysttarget 75.43 USD (+168%) · consensus 4.63/5 · 7 buy · 1 hold · 0 sell
Ownershipinsiders 2.9% · institutions 34.5% · short 5.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Quince Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consist of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
28 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Lamond Davidtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) |
| Senner Christopher J. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roberts Brigette | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Thye Dirk | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ryan Charles S.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hannah Brendantrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McLoughlin Margaret | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lamond Davidtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bray June | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Senner Christopher J. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Luca Benatti | Sell | $173.5K | SEC |
| Luca Benatti | Other | n/a (No price was disclosed in the filing) | SEC |
| Thye Dirk | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Thye Dirk | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hannah Brendantrack record | Exercise | $1.2K | SEC |
| Hannah Brendantrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hannah Brendantrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |